The Drug-Induced Cardiotoxicity Website and App

XVI.g

XVI - Hemorrhage - Bleeding - Hematoma

Alveolar hemorrhage, diffuse (ANCA-positive/-related)

Last update 17/06/2026

(Fr: Hémorragie alvéolaire avec ANCA (divers types possibles). See also under III a (bland DAH) and XII: ANCA-related vasculitis.

Causative drugs

2

Frequency - Incidence

Incidence of cardiac adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for cardiac adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.a
I.c
XII.n
XXIV.a
XXIV.b
XXIV.c
XXIV.h
XXIV.p
XXIV.q
XXIV.t
XXVI.a
XXIX.a
XXX.e
XXXIV.b
XXXIV.e
XXXIV.f
XXXIV.g
XXXVI.c
XXXVIII.c
XXXVIII.q
XII.b
XII.e
XII.g
XV.e
XVI.e
XVI.g
XX.c
XX.d
XXII.b
XXIV.k
XXVIII.a
XXVIII.d
XXIX.b
XXXVI.a
XXXVI.b
XXXVI.m
XXXVI.s
XXXVI.t
XXXVI.u
XXXVIII.a